Skip to content
DataLookout
Menu

Changes this week

Changes detected in the 7 days to Nov 21, 2026

  1. Minor: Parenting and CAH - 21-hydroxylase Deficiency Start date moved earlier from Mar 16, 2026 to Mar 13, 2026 Assistance Publique - Hôpitaux de ParisNot specified NCT06900153
  2. Minor: Empowering the Clinical Management of BMFs Through a Biological and Genetically Driven Pediatric and Adult National Network Study completion pushed from Dec 31, 2026 to Feb 28, 2027 Istituto Giannina GasliniNot specified NCT07877727
  3. Minor: Addressing Spasticity and Motor Function With Epidural Spinal Cord Stimulation Start date changed from estimate of Oct 1, 2026 to Nov 1, 2026 Kessler FoundationNot applicable NCT07890558
  4. Minor: Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS Based on the Mobile Application Start date changed from estimate of Sep 28, 2026 to Oct 7, 2026 Wonju Severance Christian HospitalNot applicable NCT07868952
  5. Minor: NEURO-COGS · Neurometabolic Mechanisms of Cognitive Training in Schizophrenia Start date pushed from Nov 16, 2026 to Nov 30, 2026 University of MinnesotaNot applicable NCT07788755
  6. Minor: Acute Hospital Care at Home · Dementia Start date pushed from Nov 17, 2026 to Dec 1, 2026 Brigham and Women's HospitalNot applicable NCT06819852
  7. Minor: Hospital Initiation of Inclisiran Treatment · Acute Coronary Syndromes Enrollment closed, study ongoing Novartis PharmaceuticalsPhase 3 NCT07102628
  8. Minor: BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment · EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04) Enrollment closed, study ongoing Sichuan Baili Pharmaceutical Co., Ltd.Phase 3 NCT06838273
  9. Minor: 5% Minoxidil Foam in Female Androgenetic Alopecia Trial completed Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.Phase 3 NCT07080931
  10. Minor: Brivaracetam in Children and · Seizures Enrollment closed, study ongoing UCB Biopharma SRLPhase 3 NCT04715646
  11. Minor: IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia Trial completed Innovent Biologics (Suzhou) Co. Ltd.Phase 3 NCT07473960
  12. Minor: Enlicitide · High Cholesterol (MK-0616-037) Trial completed Merck Sharp & Dohme LLCPhase 3 NCT07216482
  13. Minor: PYLARIFY® PET/CT or PET/MRI · Favorable Intermediate Risk (FIR) Prostate Cancer Trial completed Lantheus Medical ImagingPhase 4 NCT06074510
  14. Minor: Persistence of ACE1831, · IgG4-Related Disease Enrollment closed, study ongoing Acepodia Biotech, Inc.Phase 1/2 NCT07061938
  15. Minor: Gene Therapy Drug · Spinal Muscular Atrophy (SMA) Type 2 Patients Trial completed GeneCradle IncPhase 1/2 NCT05901987
  16. Minor: CRB-601-01 · Advanced Solid Tumor Trial completed Corbus Pharmaceuticals Inc.Phase 1/2 NCT06603844
  17. Minor: ARV-806 · Advanced Cancer That Has the KRAS G12D Mutation Trial completed Arvinas Inc.Phase 1/2 NCT07023731
  18. Minor: Basket Study of Entrectinib (RXDX-101) · Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) Trial completed Hoffmann-La RochePhase 2 NCT02568267
  19. Minor: Tirbanibulin for Pediatric Warts Trial completed The Skin Center Dermatology GroupPhase 4 NCT06791525
  20. Minor: ENV-101 · Lung Fibrosis (WHISTLE-PF Trial) Trial completed Endeavor Biomedicines, Inc.Phase 2 NCT06422884
  21. Minor: Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, · Obesity or Overweight Trial completed Eli Lilly and CompanyPhase 2 NCT06643728
  22. Minor: Eloralintide (LY3841136) in Healthy Participants Trial completed Eli Lilly and CompanyPhase 1 NCT07701083
  23. Minor: Eloralintide (LY3841136) · Obesity or Overweight Enrollment closed, study ongoing Eli Lilly and CompanyPhase 1 NCT07738614
  24. Minor: Gene Therapy Drug · Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis Enrollment closed, study ongoing GeneCradle IncPhase 1 NCT05860569
  25. Minor: SL-325 in Healthy Volunteers Trial completed Shattuck Labs, Inc.Phase 1 NCT07158437